Cresco Labs (CRLBF) Cash & Equivalents (2019 - 2026)

Cresco Labs has reported Cash & Equivalents for 7 years, with the latest figure at $32.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed N/A year-over-year to $32.3 million; the trailing twelve-month figure through Mar 2026 stood at $32.3 million (changed N/A YoY), and the FY2025 full-year result was $57.9 million, changed N/A from the prior year.
• Cash & Equivalents for Q1 2026 stood at $32.3 million, down from $57.9 million in the prior quarter.
• The five-year high for Cash & Equivalents was $112.3 million in Q2 2024, with the low at $32.3 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $76.5 million across 4 years, with a median of $80.7 million in 2023.